BioCardia, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $10.4M | $12.9M |
| FY2022 | — | $4.9M | $7.4M |
| FY2023 | — | $-1.6M | $1.1M |
| FY2024 | — | $837.0K | $2.4M |
| FY2025 | — | $895.0K | $2.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $10.4M | $12.9M |
| FY2022 | — | $4.9M | $7.4M |
| FY2023 | — | $-1.6M | $1.1M |
| FY2024 | — | $837.0K | $2.4M |
| FY2025 | — | $895.0K | $2.5M |